Merck & Co. 8-K
Leadership change
Paul J. Diaz elected to the board and named to Audit and Research committees; shareholders vote on his election in May 2027.
Filed 2026-10-13 12:36 ET
- 5.02 Officer/director change
Summary
Board appointment. Merck elected Paul J. Diaz, managing partner at Cressey & Company and a former healthcare company CEO, effective 11/01/2026. He joins the Audit and Research committees; shareholders will vote on his election in May 2027. The board will have 14 members.
Investor Takeaways
- Shareholder election of Diaz in May 2027.
The summary is written by an AI model reading the filing.
Model 005 · prompt 8bef31e277